1. Home
  2. CDNA vs ROOT Comparison

CDNA vs ROOT Comparison

Compare CDNA & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • ROOT
  • Stock Information
  • Founded
  • CDNA 1998
  • ROOT 2015
  • Country
  • CDNA United States
  • ROOT United States
  • Employees
  • CDNA N/A
  • ROOT N/A
  • Industry
  • CDNA Medical Specialities
  • ROOT Property-Casualty Insurers
  • Sector
  • CDNA Health Care
  • ROOT Finance
  • Exchange
  • CDNA Nasdaq
  • ROOT Nasdaq
  • Market Cap
  • CDNA 1.1B
  • ROOT 1.3B
  • IPO Year
  • CDNA 2014
  • ROOT 2020
  • Fundamental
  • Price
  • CDNA $23.36
  • ROOT $85.51
  • Analyst Decision
  • CDNA Buy
  • ROOT Buy
  • Analyst Count
  • CDNA 8
  • ROOT 9
  • Target Price
  • CDNA $26.43
  • ROOT $58.38
  • AVG Volume (30 Days)
  • CDNA 846.6K
  • ROOT 306.4K
  • Earning Date
  • CDNA 02-26-2025
  • ROOT 02-19-2025
  • Dividend Yield
  • CDNA N/A
  • ROOT N/A
  • EPS Growth
  • CDNA N/A
  • ROOT N/A
  • EPS
  • CDNA N/A
  • ROOT N/A
  • Revenue
  • CDNA $312,775,000.00
  • ROOT $1,044,599,999.00
  • Revenue This Year
  • CDNA $19.85
  • ROOT N/A
  • Revenue Next Year
  • CDNA $11.34
  • ROOT $8.20
  • P/E Ratio
  • CDNA N/A
  • ROOT N/A
  • Revenue Growth
  • CDNA 5.26
  • ROOT 215.11
  • 52 Week Low
  • CDNA $7.42
  • ROOT $7.22
  • 52 Week High
  • CDNA $34.84
  • ROOT $118.15
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 52.10
  • ROOT 56.84
  • Support Level
  • CDNA $22.06
  • ROOT $77.57
  • Resistance Level
  • CDNA $23.56
  • ROOT $89.92
  • Average True Range (ATR)
  • CDNA 1.69
  • ROOT 5.87
  • MACD
  • CDNA 0.12
  • ROOT 0.78
  • Stochastic Oscillator
  • CDNA 42.59
  • ROOT 75.44

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About ROOT Root Inc.

Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. The company is a direct-to-consumer personal auto insurance, renters insurance and mobile technology company. It generates revenue from the sale of auto insurance policies within the United States.

Share on Social Networks: